Salute e Benessere
Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025
Lord Cameron joined Andy Saperstein , Co-President of Morgan Stanley, for the session entitled "A Conversation on Courage", an intimate dialogue exploring leadership, philanthropy, and their shared commitment to advancing progress in rare disease research and treatment.
As Chair of the OHC Advisory Council, Lord Cameron leads international efforts to advance the Centre's bold mission: to deliver 40 new rare disease treatments by 2034. His leadership builds on a personal dedication to this cause, rooted in his family's own experience of rare disease and his role in founding Genomics England and the landmark 100,000 Genomes Project.
"
" ."
The Morgan Stanley Exchange brings together leaders in philanthropy, healthcare, and innovation to explore bold ideas for addressing global challenges. Lord Cameron's participation underscored the importance of investment, partnership, and the role of philanthropy in bridging funding gaps to deliver new treatments for rare diseases.
Photo - https://mma.prnewswire.com/media/2770472/Harrington_Discovery_Institute_image.jpg
View original content:https://www.prnewswire.co.uk/news-releases/oxford-harrington-rare-disease-centre-announces-david-cameron-chair-of-its-advisory-council-as-a-guest-speaker-at-morgan-stanley-exchange-2025-302553093.html